A New Method for Improving Checkpoint Inhibitor Therapy for Cancer
June 21, 2024
June 21, 2024
LA JOLLA, California, June 21 (TNSres) -- The Scripps Research Institute issued the following news:
* * *
Scripps Research scientists found that a "one-two punch" of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some cancers, including Hodgkin lymphoma.
* * *
Checkpoint inhibitor therapies can be thought of as the molecular "brake release" f . . .
* * *
Scripps Research scientists found that a "one-two punch" of combining the immunosuppressive drug ruxolitinib with existing checkpoint inhibitor therapies may be a more effective way to fight some cancers, including Hodgkin lymphoma.
* * *
Checkpoint inhibitor therapies can be thought of as the molecular "brake release" f . . .